Skip to main content
Premium Trial:

Request an Annual Quote

US Department of Justice Licenses Ananomouse's Bloodhound Software

NEW YORK (GenomeWeb News) – Ananomouse said today that the US Department of Justice has taken a worldwide, unlimited license for its Bloodhound kinship analysis software.
Ananomouse said that the DOJ will use the software “in support of, and as a complement to” the Federal Bureau of Investigations' Combined DNA Index System, or CODIS.
Bloodhound analyzes short tandem repeats to identify individuals and was designed to work in a range of applications such as mass fatality incidents or missing person searches.
The license with the DOJ includes an endowment of the underlying Bloodhound intellectual property “in perpetuity for humanitarian purposes,” the company said.
“The FBI is continuously seeking to develop and incorporate the best solutions for the future of forensics and for law enforcement in general,” said Thomas Callaghan, chief of the FBI’s CODIS unit, in a statement. “Ananomouse’s technology and insight is a valuable asset to our efforts.”

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.